![](https://static.wixstatic.com/media/11062b_6a134fc09ea34833a17d295e295ab517f000.jpg/v1/fill/w_1920,h_1080,al_c,q_90,enc_avif,quality_auto/11062b_6a134fc09ea34833a17d295e295ab517f000.jpg)
PharmacoKinetics (PK)
Pharmacokinetics (PK) relates to how the concentration of a drug (often measured in plasma) changes with time after dosing. Essentially pharmacokinetics drives exposure, efficacy, dosing regimens and drug-drug interactions.
Early animal PK is used to help assess predicted dose into humans and subsequent suitable human pharmacokinetics.
+Understanding the pharmacokinetics of your compound is essential
+PK does not sit in isolation and is relevant to both preclinical and clinical development
+Understand clearance and volume of distribution to allow clinical prediction
+Supports choice of toxicology species
+Enhances link between exposure and safety
+Understand correlation between pharmacokinetics, pharmacodynamics and toxicokinetics
+ Allows prediction of potential drug-drug interactions
Pharmacokinetic (PK) studies are readily conducted under contract research.
![PKPD.jpg](https://static.wixstatic.com/media/4128b0_623808769072495791ec7be8357ab956~mv2.jpg/v1/fill/w_600,h_366,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/PKPD.jpg)